Vaxxinity, Inc. (VAXX)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Oct 15, 2025, 10:27 AM EDT
Vaxxinity Market Cap
Vaxxinity has a market cap or net worth of $12.68 thousand as of October 16, 2025. Its market cap has decreased by -99.50% in one year.
Market Cap
12.68K
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since November 11, 2021, Vaxxinity's market cap has decreased from 2.08B to 12.68K, a decrease of -100.00%. That is a compound annual growth rate of -95.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2025 | 12.68K | -98.00% |
| Dec 31, 2024 | 633.74K | -99.41% |
| Dec 29, 2023 | 107.73M | -38.95% |
| Dec 30, 2022 | 176.48M | -74.91% |
| Dec 31, 2021 | 703.46M | -66.12% |
| Nov 11, 2021 | 2.08B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 749.94M |
| Elite Pharmaceuticals | 663.06M |
| Veradigm | 514.01M |
| Nika Pharmaceuticals | 495.49M |
| Northwest Biotherapeutics | 367.43M |
| CytoDyn | 350.21M |
| American Oncology Network | 283.44M |
| Silence Therapeutics | 275.85M |